rs754308516
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4BS1_SupportingBS2
The NM_001159699.2(FHL1):c.787G>A(p.Asp263Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,208,369 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D263D) has been classified as Likely benign.
Frequency
Consequence
NM_001159699.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.787G>A | p.Asp263Asn | missense_variant | 6/6 | ENST00000370683.6 | |
FHL1 | NM_001159702.3 | c.939G>A | p.Thr313= | synonymous_variant | 8/8 | ENST00000394155.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.787G>A | p.Asp263Asn | missense_variant | 6/6 | 1 | NM_001159699.2 | P1 | |
FHL1 | ENST00000394155.8 | c.939G>A | p.Thr313= | synonymous_variant | 8/8 | 5 | NM_001159702.3 |
Frequencies
GnomAD3 genomes AF: 0.0000908 AC: 10AN: 110168Hom.: 0 Cov.: 22 AF XY: 0.0000308 AC XY: 1AN XY: 32438
GnomAD3 exomes AF: 0.0000709 AC: 13AN: 183475Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67913
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1098151Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 3AN XY: 363509
GnomAD4 genome AF: 0.0000998 AC: 11AN: 110218Hom.: 0 Cov.: 22 AF XY: 0.0000615 AC XY: 2AN XY: 32498
ClinVar
Submissions by phenotype
Uruguay Faciocardiomusculoskeletal syndrome;C2678055:X-linked myopathy with postural muscle atrophy;C2678061:X-linked scapuloperoneal muscular dystrophy;C4225159:Myopathy, reducing body, X-linked, childhood-onset;C4225423:Myopathy, reducing body, X-linked, early-onset, severe Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 11, 2021 | - - |
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 247 of the FHL1 protein (p.Asp247Asn). This variant is present in population databases (rs754308516, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 198467). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 26, 2014 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The p.D247N variant (also known as c.739G>A), located in coding exon 5 of the FHL1 gene, results from a G to A substitution at nucleotide position 739. The aspartic acid at codon 247 is replaced by asparagine, an amino acid with highly similar properties. Based on data from gnomAD, the A allele has an overall frequency of 0.007% (14/204575) total alleles studied, with 3 hemizygote(s) observed. The highest observed frequency was 0.032% (9/28039) of Latino alleles. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at